SINGAPORE , Dec. 1, 2021 /PRNewswire/ -- Automated guided vehicles (AGVs) for clinical and non-clinical material handling have been used in hospitals for many years with increasing demand. Swisslog Healthcare is an established partner for AGVs in the hospital environment, with 580 installed systems and comprehensive service and implementation offerings in EMEA and APAC markets.
To take the next step and offer next-generation technology to existing and new customers, OTSAW Technology Solutions and Swisslog Healthcare have agreed to form a joint venture (JV) - OTSAW Swisslog Healthcare Robotics.
OTSAW Technology Solutions is a Singapore -based cross-regional company specializing in autonomous mobile robot solutions. The company's mobility competencies include 3D SLAM, autonomous driving level 5, sensor fusion, AI, machine learning and fleet software. This expertise coupled with extensive knowledge in hardware and software development enables the JV to introduce the next-generation of AGV solutions to the hospitals.
Swisslog Healthcare will tap on its knowledge of healthcare facilities in various markets, in addition to its realization and service strength in AGV equipment to systems are professionally installed, and existing and new systems are well-maintained.
"We are proud to have OTSAW as a partner with a passion for driving technology forward and a shared vision to enable better patient care. I am particularly impressed with OTSAW's agile, focused approach and its collaborative spirit, which always puts the customer's needs first. I am already looking forward to seeing the next generation of AGVs to be deployed in EMEA and APAC hospitals, providing tangible added value to our existing customers," said Stephan Sonderegger , CEO Swisslog Healthcare.
Ling Ting Ming , CEO at OTSAW, adds: "Across the world's healthcare systems, we experience that clinical professionals are increasingly becoming a scarce and critical resource in hospitals. Forecasts also indicate that this situation will not change in the medium term. The awareness of this challenge has increased with the global Covid 19 pandemic and has led to a growing desire in our company to use our technological know-how to make a contribution in relieving the burden on nursing staff. The fact that we are able to enter into a partnership with Swisslog Healthcare, which enables us to contribute our expertise more extensively to the healthcare sector, is not only important for OTSAW from an entrepreneurial point of view, but also a matter close to our hearts."
As part of the JV, in which OTSAW holds a 60 percent majority stake, the technology company will take over further development of the existing TransCar AGV technology. Swisslog Healthcare is entrusted to ensure continuous support of existing systems and projects with the aim of achieving the highest level of customer satisfaction.
The contractual agreement was formally signed on November 16 in Augsburg, Germany , and as a result, the JV will be operational from 1 December 2021.
OTSAW is a global pioneer in advanced robotics technologies and next-generation artificial intelligence for healthcare, security delivery and mobility applications to improve safety, business processes and everyday lives. For more information, visit www.otsaw.com
Media contacts Cecilia Yap Marketing and Communication Phone: +65 6771 5825 Email: pr@otsaw.com.sg Website: www.otsaw.com
Wood believes we're still in a strong bull market. Take advantage.
EV stocks are being dumped as a group today, even with these three names reporting good news recently.
More than 90 large-cap stocks are down at least 20% from their 2021 highs, but analysts love many of them, including JD.com, PayPal and Disney.
Buffett is taking profits off the table. It might be time to do the opposite.
Losing money in the S&P 500 is never fun. But it stings all the more when everyone else is making tons on their stocks.
Yahoo Finance Live's Jared Blikre examines the latest market action, in addition to reporting on Biogen undergoing acquisition negotiations by Samsung
A cosmetics and skin care products company founded by married Taiwanese actors Zhang Ting and Lin Ruiyang has had assets worth 600 million yuan (US$94 million) frozen due to an investigation by China's market regulator over an alleged pyramid scheme. The market regulator in Shijiazhuang, the capital of northern China's Hebei province, said it had received several reports about a suspected pyramid scheme involving Shanghai Dowell Trading, according to a letter widely circulated on Chinese social
Get aboard the Tesla stock train, argues Dan Ives at Wedbush.
It’s been a turbulent year for stock markets – record levels across all major indexes despite an onslaught of economic worries and what feels like never-ending variants of Covid-19. Now it’s time to look ahead to 10 major technology trends and which companies show the most promise to win big in 2022. Amazon (AMZN) has enjoyed the leadership position in Cloud for some time, and its AWS business now tops $16 billion in revenue a quarter.
The rally in Victoria's Secret may just be getting started, contends JP Morgan retail analyst Matt Boss.
The stock has already managed to settle below the $115 level and is moving towards yearly lows at $108.70.
Let’s talk about penny stocks. These are equities that trade for less than $5 per share, the very bottom of the price range. While they are priced that low for a reason – and the reasons may vary – low price in itself doesn’t mean that the stock’s fundamentals are sour. Smart investors can find some true bargains among the penny stocks, and set themselves up for outsized gains. The opportunity is linked to a simple question: Why is the company’s stock priced so low? If the answer is mainly benig
What happened Shares of Ocugen (NASDAQ: OCGN) were falling 5.1% as of 12:03 p.m. ET on Wednesday. The company hasn't made any announcements this week. Its stock appears to simply be continuing a slide that began in early November.
Cathie Wood's investments haven't impressed this year. But she's confident in her strategy, which includes these top growth stocks.
If you feel like inflation is outpacing the cost-of-living adjustment (COLA) planned for everyone's Social Security checks beginning in January, you're not being unreasonable. It's a fact of life that too many must-have things rose in price more than the 5.9% COLA increase scheduled for 2022. The good news is, having a stake in the right dividend stocks can help many investors more than offset this likely shortfall.
Despite their similar names, the Vanguard Total Stock Market Index and the Vanguard 500 Index funds have different objectives.
Nio (NYSE: NIO) has managed to make a place for itself in the domestic Chinese market. Nio has grown significantly in the seven years since its founding in November 2014. Nio's year-to-date deliveries through Nov. 30 rose 120.4% year over year.
Each of them truly requires a multi-year holding period to overcome their current relatively rich valuations and get the most out of them. You may not have heard the name BlackRock (NYSE: BLK), but you probably are familiar with at least one of its biggest businesses. BlackRock is the company behind the iShares family of exchange-traded funds (ETFs); it also manages traditional mutual funds and serves as the backbone for many institutional retirement plans.
Wednesday will go down in history for Codex DNA (NASDAQ: DNAY). The genetics-focused biotech saw its share price rocket 39% higher, thanks to a potentially very lucrative deal with a deep-pocketed pharmaceutical giant. Codex DNA disclosed in a regulatory filing that it has entered into a research collaboration and license agreement with U.S. pharmaceutical company Pfizer (NYSE: PFE), these days best known as the co-developer of the Comirnaty coronavirus vaccine.
Berkshire Hathaway is the ultimate Warren Buffett stock. But is it a good buy? Here's what the earnings and chart show for Berkshire stock.